Analysis of Canagliflozin in Rat Plasma After Oral Administration by Liquid Chromatographic as (Pharmacokinetic Study)
Asian Journal of Applied Chemistry Research,
The research work aims to develop a bioanalytical method using liquid chromatography and validated for the determination of canagliflozin by using an internal standard. Department of Pharmaceutical Chemistry, Smt. Kishoritai Bhoyar College of Pharmacy, New Kamptee, Nagpur (MS). Isocratic chromatography separation was achieved on an LC system with PDA detector on an ACE C18 (150mm× 4.6mm × 5µm) column using a mobile phase composition of acetonitrile: ammonium acetate buffer in the ration of 50:50 v/v (pH 4.5), orthophosphoric acid is used to adjust pH of mobile phase and the flow rate at 1.0ml/ min. and estimation was carried out at 291 nm. The retention time of a drug was 4.633 minutes. The method was validated for several parameters (specificity, linearity, precision, and accuracy) and also successfully applied for the pharmacokinetic in female rats. Calibration plot was linear (r2 > 0.9973) over the concentration range of 5-30 µg/ml for canagliflozin. The high recovery and low relative standard deviation (%RSD) confirm the suitability of the method. The result of Limit of Detection (LOD) and Limit of Quantitation (LOQ) were found to be 0.1099 μg/ml and 0.3331 μg/ml, respectively. The new RP-HPLC method can be conveniently adapted for examining canagliflozin concentration in rat plasma after oral administration.
- high-performance liquid chromatography
- method validation
- pharmacokinetic assessment
How to Cite
Mamidi RN, Cuyckens F, Chen J, Scheers E, Kalamaridis D, Lin R, et al. Metabolism and Excretion of Canagliflozin in Mice, Rats, Dogs, and Humans. Drug Metab Dispos. 2014;42(5):903–16.
Kaushal S, Singh H, Thangaraju P, Singh J. Canagliflozin: A Novel SGLT-2 inhibitor for Type-2 Diabetes Mellitus. North American Journal of Medical Science. 2014;6(3):107-113.
Canagliflozin. Pub Chem Open Chemistry Database. US: National Institutes of Health. Accessed 12 July 2021.
Chemistry Review(S) – FDA. Accessed 12 July 2021.
Patel ND, Shah DB, Maheshwari DG. Development and Validation of UV-Spectrophotometric Estimation of Canagliflozin in Its Pharmaceutical Dosage Form. 2015;7(3):9779-9784.
Kaur I, Wakode S, Singh HP. Development and Validation of a Stability-Indicating High Performance Thin Layer Chromatography (HPTLC) Method for Estimation of Canagliflozin in Bulk and Pharmaceutical Dosage Form Pharmaceutical Science. Journal of Applied Pharmaceutical Science. 2016;6 (05):051-057.
Blagden N, Matas M, Gavan PT, York P. Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates. Advanced Drug Delivery Reviews. 2007;59(7):617-630.
ICH Guideline, “Validation of analytical procedures: text and methodology,” in Proceedings of International Conference on Harmonization, Topic Q2 (R1); 2005.
Accessed 12 July 2021.
FDA, CDER, Beers, and Donald, Analytical Procedures and Methods Validation for Drugs and Biologics Guidance for Industry, FDA, Silver Spring; 2015.
Accessed 12 July 2021.
Batrawi N, Naseef H, Al-Rimawi F., Development and validation of a stability-indicating HPLC method for the simultaneous determination of florfenicol and flunixin meglumine combination in an injectable solution. Journal of Analytical Methods in Chemistry. 2017;1-7.
Suneetha A, Sharmila D. A Validated Stability Indicating RP-HPLC Method for Estimation of Canagliflozin in Dosage Form. Res. J Pharma., Biol. Chemical Sci, 2015;6(5):1186-94.
Abstract View: 70 times
PDF Download: 28 times